Search tips
Search criteria 


Logo of ijpsychHomeCurrent issueInstructionsSubmit article
Indian J Psychiatry. 2004 Oct-Dec; 46(4): 299–309.
PMCID: PMC2950948

Cannabis and Psychopathology : Update 2004


The study of cannabis use and psychopathology remains an interesting area from both academic and pragmatic perspectives. This article provides an update on the progress made in this area over the past decade or so. Psychopathology and psychiatric syndromes associated with cannabis use that have received research attention in recent years include cannabis withdrawal, cannabis and psychotic disorders (especially schizophrenia), depression, anxiety, and cognitive impairment. Status of a specific cannabis withdrawal syndrome and a specific ‘cannabis psychosis’ remains controversial. Current evidence indicates that there is a clinically significant association between cannabis use disorders and psychotic syndromes, depression, anxiety and possibly mild cognitive impairment. However, the nature of this association is often not clear. Several hypothesis related to the cannabis-schizophrenia association are examined. Cannabis use might be casually related to the later development of schizophrenia in an indirect way in a few heavy users, but more commonly, its use may precipitate disorders in persons who are vulnerable to developing psychosis and worsen the course of the disorder.

Keywords: Cannabis, psychopathology, withdrawal, psychosis, schizophrenia, depression, mania, anxiety

Full Text

The Full Text of this article is available as a PDF (573K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Allebeck P, Adamsson C, Engström A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County. Acta Psychiatr Scand. 1993 Jul;88(1):21–24. [PubMed]
  • Andréasson S, Allebeck P, Engström A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987 Dec 26;2(8574):1483–1486. [PubMed]
  • Arendt Mikkel, Munk-Jørgensen Povl. Heavy cannabis users seeking treatment- prevalence of psychiatric disorders. Soc Psychiatry Psychiatr Epidemiol. 2004 Feb;39(2):97–105. [PubMed]
  • Arseneault Louise, Cannon Mary, Poulton Richie, Murray Robin, Caspi Avshalom, Moffitt Terrie E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002 Nov 23;325(7374):1212–1213. [PMC free article] [PubMed]
  • Arseneault Louise, Cannon Mary, Witton John, Murray Robin M. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004 Feb;184:110–117. [PubMed]
  • Bamrah JS, Freeman HL, Goldberg DP. Epidemiology of schizophrenia in Salford, 1974-84. Changes in an urban community over ten years. Br J Psychiatry. 1991 Dec;159:802–810. [PubMed]
  • Basu D, Malhotra A, Bhagat A, Varma VK. Cannabis psychosis and acute schizophrenia. a case-control study from India. Eur Addict Res. 1999 Jun;5(2):71–73. [PubMed]
  • Batel P. Addiction and schizophrenia. Eur Psychiatry. 2000 Mar;15(2):115–122. [PubMed]
  • Blanchard JJ, Brown SA, Horan WP, Sherwood AR. Substance use disorders in schizophrenia: review, integration, and a proposed model. Clin Psychol Rev. 2000 Mar;20(2):207–234. [PubMed]
  • Block RI, Ghoneim MM. Effects of chronic marijuana use on human cognition. Psychopharmacology (Berl) 1993;110(1-2):219–228. [PubMed]
  • Boutros NN, Bowers MB., Jr Chronic substance-induced psychotic disorders: state of the literature. J Neuropsychiatry Clin Neurosci. 1996 Summer;8(3):262–269. [PubMed]
  • Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry. 2001 Dec;158(12):2033–2037. [PubMed]
  • Brook JS, Cohen P, Brook DW. Longitudinal study of co-occurring psychiatric disorders and substance use. J Am Acad Child Adolesc Psychiatry. 1998 Mar;37(3):322–330. [PubMed]
  • Budney Alan J, Moore Brent A, Vandrey Ryan G, Hughes John R. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003 Aug;112(3):393–402. [PubMed]
  • Budney AJ, Novy PL, Hughes JR. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction. 1999 Sep;94(9):1311–1322. [PubMed]
  • Chaudry HR, Moss HB, Bashir A, Suliman T. Cannabis psychosis following bhang ingestion. Br J Addict. 1991 Sep;86(9):1075–1081. [PubMed]
  • Chen Chuan-Yu, Wagner Fernando A, Anthony James C. Marijuana use and the risk of Major Depressive Episode. Epidemiological evidence from the United States National Comorbidity Survey. Soc Psychiatry Psychiatr Epidemiol. 2002 May;37(5):199–206. [PubMed]
  • Compton WM, 3rd, Cottler LB, Phelps DL, Ben Abdallah A, Spitznagel EL. Psychiatric disorders among drug dependent subjects: are they primary or secondary? Am J Addict. 2000 Spring;9(2):126–134. [PubMed]
  • Cottler LB, Schuckit MA, Helzer JE, Crowley T, Woody G, Nathan P, Hughes J. The DSM-IV field trial for substance use disorders: major results. Drug Alcohol Depend. 1995 Apr;38(1):59–83. [PubMed]
  • Cuffel BJ, Heithoff KA, Lawson W. Correlates of patterns of substance abuse among patients with schizophrenia. Hosp Community Psychiatry. 1993 Mar;44(3):247–251. [PubMed]
  • Dannon Pinhas N, Lowengrub Katherine, Amiaz Revital, Grunhaus Leon, Kotler Moshe. Comorbid cannabis use and panic disorder: short term and long term follow-up study. Hum Psychopharmacol. 2004 Mar;19(2):97–101. [PubMed]
  • Deas D, Gerding L, Hazy J. Marijuana and panic disorder. J Am Acad Child Adolesc Psychiatry. 2000 Dec;39(12):1467–1467. [PubMed]
  • Degenhardt Louisa, Hall Wayne, Lynskey Michael. Exploring the association between cannabis use and depression. Addiction. 2003 Nov;98(11):1493–1504. [PubMed]
  • Degenhardt L, Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med. 2001 May;31(4):659–668. [PubMed]
  • Degenhardt L, Hall W, Lynskey M. The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. Soc Psychiatry Psychiatr Epidemiol. 2001 May;36(5):219–227. [PubMed]
  • Dixon L, Haas G, Weiden P, Sweeney J, Frances A. Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr Bull. 1990;16(1):69–79. [PubMed]
  • Ehrenreich H, Rinn T, Kunert HJ, Moeller MR, Poser W, Schilling L, Gigerenzer G, Hoehe MR. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl) 1999 Mar;142(3):295–301. [PubMed]
  • Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med. 2003 Jan;33(1):15–21. [PubMed]
  • Field T, Diego M, Sanders CE. Adolescent suicidal ideation. Adolescence. 2001 Summer;36(142):241–248. [PubMed]
  • Fletcher JM, Page JB, Francis DJ, Copeland K, Naus MJ, Davis CM, Morris R, Krauskopf D, Satz P. Cognitive correlates of long-term cannabis use in Costa Rican men. Arch Gen Psychiatry. 1996 Nov;53(11):1051–1057. [PubMed]
  • Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull. 1998;24(3):443–455. [PubMed]
  • Geddes JR, Black RJ, Whalley LJ, Eagles JM. Persistence of the decline in the diagnosis of schizophrenia among first admissions to Scottish hospitals from 1969 to 1988. Br J Psychiatry. 1993 Nov;163:620–626. [PubMed]
  • Georgotas A, Zeidenberg P. Observations on the effects of four weeks of heavy marihuana smoking on group interaction and individual behavior. Compr Psychiatry. 1979 Sep-Oct;20(5):427–432. [PubMed]
  • Grant BF. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J Subst Abuse. 1995;7(4):481–497. [PubMed]
  • Green BE, Ritter C. Marijuana use and depression. J Health Soc Behav. 2000 Mar;41(1):40–49. [PubMed]
  • Greenberg I, Mendelson JH, Kuehnle JC, Mello N, Babor TF. Psychiatric and behavioral observations of casual and heavy marijuana users in a controlled research setting. Ann N Y Acad Sci. 1976;282:72–84. [PubMed]
  • Grinspoon L, Bakalar JB. The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. J Psychoactive Drugs. 1998 Apr-Jun;30(2):171–177. [PubMed]
  • Grotenhermen Franjo. Pharmacology of cannabinoids. Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):14–23. [PubMed]
  • Hall W. Cannabis use and psychosis. Drug Alcohol Rev. 1998 Dec;17(4):433–444. [PubMed]
  • Hall W, Degenhardt L. Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust N Z J Psychiatry. 2000 Feb;34(1):26–34. [PubMed]
  • Hall W, Solowij N. Adverse effects of cannabis. Lancet. 1998 Nov 14;352(9140):1611–1616. [PubMed]
  • Hambrecht M, Häfner H. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust N Z J Psychiatry. 2000 Jun;34(3):468–475. [PubMed]
  • Hamera E, Schneider JK, Deviney S. Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. J Nerv Ment Dis. 1995 Sep;183(9):559–565. [PubMed]
  • Haney Margaret, Hart Carl L, Vosburg Suzanne K, Nasser Jennifer, Bennett Andrew, Zubaran Carlos, Foltin Richard W. Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology. 2004 Jan;29(1):158–170. [PubMed]
  • Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) 1999 Feb;141(4):395–404. [PubMed]
  • Harrison G, Cooper JE, Gancarczyk R. Changes in the administrative incidence of schizophrenia. Br J Psychiatry. 1991 Dec;159:811–816. [PubMed]
  • Imade AG, Ebie JC. A retrospective study of symptom patterns of cannabis-induced psychosis. Acta Psychiatr Scand. 1991 Feb;83(2):134–136. [PubMed]
  • Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl. 1992;20:1–97. [PubMed]
  • Johns A. Psychiatric effects of cannabis. Br J Psychiatry. 2001 Feb;178:116–122. [PubMed]
  • Jones RT, Benowitz N, Bachman J. Clinical studies of cannabis tolerance and dependence. Ann N Y Acad Sci. 1976;282:221–239. [PubMed]
  • Kendell RE, Malcolm DE, Adams W. The problem of detecting changes in the incidence of schizophrenia. Br J Psychiatry. 1993 Feb;162:212–218. [PubMed]
  • Kouri E, Pope HG, Jr, Yurgelun-Todd D, Gruber S. Attributes of heavy vs. occasional marijuana smokers in a college population. Biol Psychiatry. 1995 Oct 1;38(7):475–481. [PubMed]
  • Kouri EM, Pope HG, Jr, Lukas SE. Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology (Berl) 1999 Apr;143(3):302–308. [PubMed]
  • Langs G, Fabisch H, Fabisch K, Zapotoczky H. Can cannabis trigger recurrent panic attacks in susceptible patients? Eur Psychiatry. 1997;12(8):415–419. [PubMed]
  • Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry. 1994 Apr;51(4):273–279. [PubMed]
  • Mathers DC, Ghodse AH, Caan AW, Scott SA. Cannabis use in a large sample of acute psychiatric admissions. Br J Addict. 1991 Jun;86(6):779–784. [PubMed]
  • McGee R, Williams S, Poulton R, Moffitt T. A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction. 2000 Apr;95(4):491–503. [PubMed]
  • McGuire PK, Jones P, Harvey I, Williams M, McGuffin P, Murray RM. Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophr Res. 1995 May;15(3):277–281. [PubMed]
  • McKay DR, Tennant CC. Is the grass greener? The link between cannabis and psychosis. Med J Aust. 2000 Mar 20;172(6):284–286. [PubMed]
  • Milich R, Lynam D, Zimmerman R, Logan TK, Martin C, Leukefeld C, Portis C, Miller J, Clayton R. Differences in young adult psychopathology among drug abstainers, experimenters, and frequent users. J Subst Abuse. 2000;11(1):69–88. [PubMed]
  • Moran C. Depersonalization and agoraphobia associated with marijuana use. Br J Med Psychol. 1986 Jun;59(Pt 2):187–196. [PubMed]
  • Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull. 1990;16(1):31–56. [PubMed]
  • Mueser KT, Bellack AS, Blanchard JJ. Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol. 1992 Dec;60(6):845–856. [PubMed]
  • Mueser KT, Drake RE, Wallach MA. Dual diagnosis: a review of etiological theories. Addict Behav. 1998 Nov-Dec;23(6):717–734. [PubMed]
  • Munk-Jørgensen P. Decreasing rates of incident schizophrenia cases in psychiatric service: A review of the literature. Eur Psychiatry. 1995;10(3):129–141. [PubMed]
  • Musty RE, Kaback L. Relationships between motivation and depression in chronic marijuana users. Life Sci. 1995;56(23-24):2151–2158. [PubMed]
  • Negrete JC, Knapp WP, Douglas DE, Smith WB. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med. 1986 Aug;16(3):515–520. [PubMed]
  • Niveau G. Flash-back cannabique, un cas médico-légal. Encephale. 2002 Jan-Feb;28(1):77–79. [PubMed]
  • Patton George C, Coffey Carolyn, Carlin John B, Degenhardt Louisa, Lynskey Michael, Hall Wayne. Cannabis use and mental health in young people: cohort study. BMJ. 2002 Nov 23;325(7374):1195–1198. [PMC free article] [PubMed]
  • Poole R, Brabbins C. Drug induced psychosis. Br J Psychiatry. 1996 Feb;168(2):135–138. [PubMed]
  • Pope HG, Jr, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA. 1996 Feb 21;275(7):521–527. [PubMed]
  • Reilly D, Didcott P, Swift W, Hall W. Long-term cannabis use: characteristics of users in an Australian rural area. Addiction. 1998 Jun;93(6):837–846. [PubMed]
  • Rey Joseph M, Tennant Christopher C. Cannabis and mental health. BMJ. 2002 Nov 23;325(7374):1183–1184. [PMC free article] [PubMed]
  • Rey Joseph M, Sawyer Michael G, Raphael Beverley, Patton George C, Lynskey Michael. Mental health of teenagers who use cannabis. Results of an Australian survey. Br J Psychiatry. 2002 Mar;180:216–221. [PubMed]
  • Rolfe M, Tang CM, Sabally S, Todd JE, Sam EB, Hatib N'Jie AB. Psychosis and cannabis abuse in The Gambia. A case-control study. Br J Psychiatry. 1993 Dec;163:798–801. [PubMed]
  • Rottanburg D, Robins AH, Ben-Arie O, Teggin A, Elk R. Cannabis-associated psychosis with hypomanic features. Lancet. 1982 Dec 18;2(8312):1364–1366. [PubMed]
  • Rowe MG, Fleming MF, Barry KL, Manwell LB, Kropp S. Correlates of depression in primary care. J Fam Pract. 1995 Dec;41(6):551–558. [PubMed]
  • Sarkar Jaydip, Murthy Pratima, Singh Swaran P. Psychiatric morbidity of cannabis abuse. Indian J Psychiatry. 2003 Jul;45(3):182–188. [PMC free article] [PubMed]
  • Solowij N, Michie PT, Fox AM. Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry. 1995 May 15;37(10):731–739. [PubMed]
  • Smit Filip, Bolier Linda, Cuijpers Pim. Cannabis use and the risk of later schizophrenia: a review. Addiction. 2004 Apr;99(4):425–430. [PubMed]
  • Solowij N. Do cognitive impairments recover following cessation of cannabis use? Life Sci. 1995;56(23-24):2119–2126. [PubMed]
  • Strakowski SM, McElroy SL, Keck PE, Jr, West SA. The effects of antecedent substance abuse on the development of first-episode psychotic mania. J Psychiatr Res. 1996 Jan-Feb;30(1):59–68. [PubMed]
  • Strakowski SM, DelBello MP, Fleck DE, Arndt S. The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry. 2000 Sep 15;48(6):477–485. [PubMed]
  • Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000 Oct;157(10):1552–1562. [PubMed]
  • Suvisaari JM, Haukka JK, Tanskanen AJ, Lönnqvist JK. Decline in the incidence of schizophrenia in Finnish cohorts born from 1954 to 1965. Arch Gen Psychiatry. 1999 Aug;56(8):733–740. [PubMed]
  • Thomas H. Psychiatric symptoms in cannabis users. Br J Psychiatry. 1993 Aug;163:141–149. [PubMed]
  • Thomas H. A community survey of adverse effects of cannabis use. Drug Alcohol Depend. 1996 Nov;42(3):201–207. [PubMed]
  • Thornicroft G. Cannabis and psychosis. Is there epidemiological evidence for an association? Br J Psychiatry. 1990 Jul;157:25–33. [PubMed]
  • Tien AY, Anthony JC. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. J Nerv Ment Dis. 1990 Aug;178(8):473–480. [PubMed]
  • Tournier Marie, Sorbara Frédéric, Gindre Claire, Swendsen Joel D, Verdoux Hélène. Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population. Psychiatry Res. 2003 May 1;118(1):1–8. [PubMed]
  • Troisi A, Pasini A, Saracco M, Spalletta G. Psychiatric symptoms in male cannabis users not using other illicit drugs. Addiction. 1998 Apr;93(4):487–492. [PubMed]
  • van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol. 2002 Aug 15;156(4):319–327. [PubMed]
  • Weiser Mark, Knobler Haim Y, Noy Shlomo, Kaplan Zeev. Clinical characteristics of adolescents later hospitalized for schizophrenia. Am J Med Genet. 2002 Dec 8;114(8):949–955. [PubMed]
  • Wiesbeck GA, Schuckit MA, Kalmijn JA, Tipp JE, Bucholz KK, Smith TL. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction. 1996 Oct;91(10):1469–1478. [PubMed]
  • Wray I, Dickerson MG. Cessation of high frequency gambling and "withdrawal' symptoms. Br J Addict. 1981 Dec;76(4):401–405. [PubMed]
  • Zammit Stanley, Allebeck Peter, Andreasson Sven, Lundberg Ingvar, Lewis Glyn. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ. 2002 Nov 23;325(7374):1199–1199. [PMC free article] [PubMed]
  • Ziedonis DM, Trudeau K. Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophr Bull. 1997;23(2):229–238. [PubMed]

Articles from Indian Journal of Psychiatry are provided here courtesy of Wolters Kluwer -- Medknow Publications